Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Wolfgang Rudy is active.

Publication


Featured researches published by Wolfgang Rudy.


Cell | 1991

A NEW VARIANT OF GLYCOPROTEIN CD44 CONFERS METASTATIC POTENTIAL TO RAT CARCINOMA CELLS

Ursula Günthert; Martin Hofmann; Wolfgang Rudy; Sonja Reber; Margot Zöller; Irmgard Hauβmann; Siegfried Matzku; Achim Wenzel; Helmut Ponta; Peter Herrlich

Using a monoclonal antibody (MAb1.1ASML) raised against a surface glycoprotein of the metastasizing rat pancreatic carcinoma cell line BSp73ASML, cDNA clones have been isolated that encode glycoproteins with partial homology to CD44, a presumed adhesion molecule. In one of the clones, pMeta-1, the epitope marks an additional extracellular domain of 162 amino acids inserted into the rat CD44 protein between amino acid positions 223 and 247 (by analogy to human and murine CD44). The new variants are expressed only in the metastasizing cell lines of two rat tumors, the pancreatic carcinoma BSp73 and the mammary adenocarcinoma 13762NF; they are not expressed in the non-metastasizing tumor cell lines nor in most normal rat tissues. Overexpression of pMeta-1 in the nonmetastasizing BSp73AS cells suffices to establish full metastatic behavior.


Archive | 1993

Cd44 and Splice Variants of Cd44 in Normal Differentiation and Tumor Progression

Peter Herrlich; Wolfgang Rudy; Martin Hofmann; Robert Arch; Margot Zöller; Volker Zawadzki; Cornelia Tölg; Armin Hekele; Gerrit Koopman; Steven T. Pals; Karl-Heinz Heider; Jonathan P. Sleeman; Helmut Ponta

CD44, originally defined by antibodies as a leukocyte surface protein (reviewed in Haynes et al., 1989), has become a polymorphic family of proteins expressed in various cells and conditions. The polymorphism is due to differential modifications and to splice variation (Hughes et al., 1983; Omary et al., 1988; Kansas et al., 1989; Picker et al., 1989; Goldstein et al., 1989; Goldstein and Butcher, 1990; Stamenkovic et al., 1991, Dougherty et al., 1991; Brown et al., 1991; Gunthert et al., 1991; Shtivelman and Bishop, 1991; Jackson et al., 1992). Because of the polymorphism a multitude of functions can be expected. Yet these need t be defined. All or part of the CD44 glycoproteins have affinity for hyaluronic acid, some forms are linked to chondoitin sulfate and bind fibronectin and collagen (Aruffo et al., 1990; Miyake et al., 1990; Stamenkovic et al., 1989; Goldstein et al., 1989; Wolffe et al. 1990; Carter and Wayner, 1988; Jalkanen and Jalkanen, 1992). These affinnites may have functions in association with different primary structures domains introduced by splice variation.


Cancer Research | 1991

CD44 Splice Variants Confer Metastatic Behavior in Rats: Homologous Sequences Are Expressed in Human Tumor Cell Lines

Martin Hofmann; Wolfgang Rudy; Margot Zöller; Cornelia Tölg; Helmut Ponta; Peter Herrlich; Ursula Günthert


Cancer Research | 1993

The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants : each one individually suffices to confer metastatic behavior

Wolfgang Rudy; Martin Hofmann; Reinhard Schwartz-Albiez; Margot Zöller; Karl-Heinz Heider; Helmut Ponta; Peter Herrlich


Cancer Research | 1993

A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells.

Martin Hofmann; Wolfgang Rudy; Ursula Günthert; Stephen G. Zimmer; Volker Zawadzki; Margot Zöller; Rosemarie Lichtner; Peter Herrlich; Helmut Ponta


Journal of Cell Biology | 1996

Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity.

Jonathan P. Sleeman; Wolfgang Rudy; Martin Hofmann; Jiirgen Moll; Peter Herrlich; Helmut Ponta


Cancer Research | 1996

Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells.

Jonathan P. Sleeman; Sigrid Arming; Jürgen Moll; Armin Hekele; Wolfgang Rudy; Larry S. Sherman; Günther Kreil; Helmut Ponta; Peter Herrlich


Archive | 2003

Method for solution based diagnosis

Rüdiger Ridder; Wolfgang Rudy; Matthias Herkert; Marcus Trunk-Gehmacher; Anja Reichert; Magnus Von Knebel Doeberitz


Cancer Research | 2002

CD40-expressing carcinoma cells induce down-regulation of CD40 ligand (CD154) and impair T-cell functions

Richard Batrla; Wolfgang Rudy; Susanne Stumm; Diethelm Wallwiener; Brigitte Gückel


Archive | 2001

Immunization of an individual against carcinomas and the preliminary stages thereof

Magnus Von Knebel Doeberitz; Michael Linnebacher; Wolfgang Rudy

Collaboration


Dive into the Wolfgang Rudy's collaboration.

Top Co-Authors

Avatar

Helmut Ponta

Karlsruhe Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Martin Hofmann

Karlsruhe Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Margot Zöller

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ursula Günthert

Karlsruhe Institute of Technology

View shared research outputs
Researchain Logo
Decentralizing Knowledge